SherlockMS and the Case of the Confused Appetite

This evening, a fresh paper from The Lancet lay on my desk. No wax seal, no dramatic message. Just pure, unadulterated data. The title: “Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity”. The central finding, in layman's terms: a medication used for weight loss and diabetes significantly reduces alcohol consumption in people with alcohol use disorder.

I raised an eyebrow. A barely perceptible smile. “Ah,” I murmured. “The classic case of the accomplice within.”

The Reward Centre

The scene of this crime is not a place you can find on a map. It lies deep within our brains. Imagine the brain as a vast metropolis. The crime scene is this city's pleasure district—a complex network of areas like the nucleus accumbens and the ventral tegmental area. This is where reward is processed, desire is born, and appetite is controlled. It is a place where the signals for hunger for food and the craving for alcohol travel down the same crowded boulevards. A loud, chaotic, but vital place. And it is precisely here that a silent culprit has taken control.

Self-Control

The victim in this case is abstract, yet fundamental: control. The ability to stop after one glass of wine. The freedom not to have to drink. In alcohol use disorder, the brain's city hall—the prefrontal cortex—is drowned out by the loud cries from the pleasure district. The rational mayor is deposed by a charismatic gangster boss named "Alcohol." The victim is free will, suffocated under the dictatorship of desire.

The Old Methods

Previous investigations into this case focused on two main strategies. Either one tries to deny the gangster boss access to his clubs (with drugs like naltrexone, which blocks opioid receptors) or one makes the stay in the city as unpleasant as possible (with disulfiram, which causes severe hangover symptoms). These methods have their merits, but they do not work for everyone. They are like fighting a fire by merely locking the doors while ignoring the source of the ignition. The hypothesis was: you must attack the alcohol itself or its direct effects. Sweet.

The 'Semaglutide' File

The paper by Klausen and colleagues presents the facts irrefutably. A randomized, double-blind, placebo-controlled trial—the gold standard of clinical investigation. 108 patients with alcohol use disorder and obesity were divided into two groups. One received weekly semaglutide, a drug that mimics the body's own hormone GLP-1. The other received a placebo. The result after 26 weeks: the semaglutide group had reduced their heavy drinking days by 41.1 percentage points, the placebo group by only 26.4. A difference of nearly 14 percentage points. These are not anecdotes. These are paving stones.

I imagine one of the participants, let's call him Mr. Davies. A man who has struggled for years with his weight and his evening beer. After a few weeks in the study, he notices something strange. “It’s not that I’m not allowed to drink,” he explains to his therapist, who in my imagination is, of course, a capable but perpetually slightly bewildered Watson-type. “It’s more that I... forget to want to. The thought of a cold beer after work has lost its lustre.” At the same time, without trying, he has lost five kilos. His therapist notes this as an interesting side effect. I would have recognised it as the culprit's signature.

A False Key Fits

Here lies the brilliant, decisive twist in the case. Semaglutide was not developed to treat alcohol addiction. It was designed to regulate blood sugar and increase the feeling of fullness. It mimics the hormone GLP-1, which our gut releases after a meal to signal to the brain: “We are full.” But this signal doesn't just arrive at the "Hunger" department. It also lands on the desk of the "Reward" department. The crucial finding is that the mechanism that curbs our appetite for food also dampens the craving for alcohol.

The Overactive Reward System

The true culprit is therefore not the alcohol itself, but the mechanism that makes it so irresistible: an overactive, misguided reward system. In this case, semaglutide is not the investigator but the tool that outsmarts the culprit. GLP-1 receptors are found not only in the gut but also in those brain regions responsible for motivation and desire. Semaglutide, the GLP-1 agonist, docks onto these receptors and whispers in the brain's ear: “Relax. The reward is not as great as you think.” It reduces the so-called "incentive salience", the shine, the allure, that emanates from everything associated with alcohol. The accomplices, in this case, are the overlapping neural circuits our brain uses for reward from both food and drugs. A clever move by evolution, which we are now using against it.

Back in Baker Street, I was sitting in my room again. Naturally. The rain had subsided. I made a note in my leather-bound book.

• The Crime: The loss of control, driven by a hijacked desire.
• The Main Culprit: An overactive reward system that makes no distinction between survival and self-destruction.
• The Accomplices: Shared neural pathways for food and drug reward.
• The Investigative Tool: A hormone mimic (semaglutide) that recalibrates the reward system.

Most detectives hunt culprits in the dark. I hunt culprits in the light of neuropharmacology. And yet, the brain is always the better storyteller.

Outside, London roared. Inside, I was already thinking of the next case. For somewhere, in some neural circuit, a desire is being hijacked—and only a neuro-detective will notice the difference.

With a sharp mind and British humour, Your SherlockMS